HEADER TRANSFERASE 08-AUG-03 1Q5K TITLE CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL: HIGH FIVE CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.BHAT,Y.XUE,S.BERG,S.HELLBERG,M.ORMO,Y.NILSSON,A.C.RADESATER, AUTHOR 2 E.JERNING,P.O.MARKGREN,T.BORGEGARD,M.NYLOF,A.GIMENEZ-CASSINA, AUTHOR 3 F.HERNANDEZ,J.J.LUCAS,J.DIAZ-MIDO,J.AVILA REVDAT 3 14-FEB-24 1Q5K 1 REMARK REVDAT 2 24-FEB-09 1Q5K 1 VERSN REVDAT 1 10-AUG-04 1Q5K 0 JRNL AUTH R.BHAT,Y.XUE,S.BERG,S.HELLBERG,M.ORMO,Y.NILSSON, JRNL AUTH 2 A.C.RADESATER,E.JERNING,P.O.MARKGREN,T.BORGEGARD,M.NYLOF, JRNL AUTH 3 A.GIMENEZ-CASSINA,F.HERNANDEZ,J.J.LUCAS,J.DIAZ-NIDO,J.AVILA JRNL TITL STRUCTURAL INSIGHTS AND BIOLOGICAL EFFECTS OF GLYCOGEN JRNL TITL 2 SYNTHASE KINASE 3-SPECIFIC INHIBITOR AR-A014418. JRNL REF J.BIOL.CHEM. V. 278 45937 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12928438 JRNL DOI 10.1074/JBC.M306268200 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2437760.630 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.2 REMARK 3 NUMBER OF REFLECTIONS : 78753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.400 REMARK 3 FREE R VALUE TEST SET COUNT : 2670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 78815 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8824 REMARK 3 BIN R VALUE (WORKING SET) : 0.2740 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 310 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5515 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 373 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.75000 REMARK 3 B22 (A**2) : 9.97000 REMARK 3 B33 (A**2) : -11.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.230 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.710 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.610 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 43.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : INH.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : INH.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q5K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000019943. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0064 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 78815 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.29200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.21200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.45650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 89.21200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.29200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.45650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 ASN A 287 REMARK 465 TYR A 288 REMARK 465 THR A 289 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 ASN B 287 REMARK 465 TYR B 288 REMARK 465 THR B 289 REMARK 465 GLN B 295 REMARK 465 ILE B 296 REMARK 465 LYS B 297 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 93 135.75 140.54 REMARK 500 LYS A 123 -72.30 63.03 REMARK 500 ASP A 181 47.18 -153.43 REMARK 500 ASP A 200 81.90 56.25 REMARK 500 CYS A 218 134.14 78.79 REMARK 500 TYR A 221 -34.41 99.66 REMARK 500 GLN A 295 97.04 -69.06 REMARK 500 ASN A 370 74.10 -173.13 REMARK 500 ARG A 383 51.77 37.72 REMARK 500 SER B 66 -52.64 -27.46 REMARK 500 PHE B 67 -72.52 -61.99 REMARK 500 SER B 118 -152.60 -176.01 REMARK 500 LYS B 123 77.96 -6.57 REMARK 500 ASP B 124 -82.96 150.87 REMARK 500 GLU B 125 126.46 -32.36 REMARK 500 ASP B 181 43.10 -148.70 REMARK 500 ASP B 200 79.46 58.86 REMARK 500 CYS B 218 135.72 75.09 REMARK 500 TYR B 221 -37.01 93.62 REMARK 500 PHE B 291 -122.66 -138.90 REMARK 500 PRO B 300 -91.68 -54.66 REMARK 500 TRP B 301 -37.97 -170.50 REMARK 500 ASN B 370 75.17 -170.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TMU A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TMU B 902 DBREF 1Q5K A 7 420 UNP P49841 GSK3B_HUMAN 7 420 DBREF 1Q5K B 7 420 UNP P49841 GSK3B_HUMAN 7 420 SEQRES 1 A 414 THR THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN SEQRES 2 A 414 PRO SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS SEQRES 3 A 414 ASP GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY SEQRES 4 A 414 GLN GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP SEQRES 5 A 414 THR LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR SEQRES 6 A 414 GLN ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE SEQRES 7 A 414 LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU SEQRES 8 A 414 LEU GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL SEQRES 9 A 414 ARG LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS SEQRES 10 A 414 ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO SEQRES 11 A 414 GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA SEQRES 12 A 414 LYS GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET SEQRES 13 A 414 TYR GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE SEQRES 14 A 414 GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU SEQRES 15 A 414 LEU ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE SEQRES 16 A 414 GLY SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SEQRES 17 A 414 SER TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU SEQRES 18 A 414 ILE PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL SEQRES 19 A 414 TRP SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY SEQRES 20 A 414 GLN PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU SEQRES 21 A 414 VAL GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU SEQRES 22 A 414 GLN ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS SEQRES 23 A 414 PHE PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE SEQRES 24 A 414 ARG PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER SEQRES 25 A 414 ARG LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO SEQRES 26 A 414 LEU GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG SEQRES 27 A 414 ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO SEQRES 28 A 414 ALA LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN SEQRES 29 A 414 PRO PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG SEQRES 30 A 414 ILE GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA SEQRES 31 A 414 ALA SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN SEQRES 32 A 414 ASN ALA ALA SER ALA SER ALA SER ASN SER THR SEQRES 1 B 414 THR THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN SEQRES 2 B 414 PRO SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS SEQRES 3 B 414 ASP GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY SEQRES 4 B 414 GLN GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP SEQRES 5 B 414 THR LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR SEQRES 6 B 414 GLN ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE SEQRES 7 B 414 LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU SEQRES 8 B 414 LEU GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL SEQRES 9 B 414 ARG LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS SEQRES 10 B 414 ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO SEQRES 11 B 414 GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA SEQRES 12 B 414 LYS GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET SEQRES 13 B 414 TYR GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE SEQRES 14 B 414 GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU SEQRES 15 B 414 LEU ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE SEQRES 16 B 414 GLY SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SEQRES 17 B 414 SER TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU SEQRES 18 B 414 ILE PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL SEQRES 19 B 414 TRP SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY SEQRES 20 B 414 GLN PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU SEQRES 21 B 414 VAL GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU SEQRES 22 B 414 GLN ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS SEQRES 23 B 414 PHE PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE SEQRES 24 B 414 ARG PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER SEQRES 25 B 414 ARG LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO SEQRES 26 B 414 LEU GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG SEQRES 27 B 414 ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO SEQRES 28 B 414 ALA LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN SEQRES 29 B 414 PRO PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG SEQRES 30 B 414 ILE GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA SEQRES 31 B 414 ALA SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN SEQRES 32 B 414 ASN ALA ALA SER ALA SER ALA SER ASN SER THR HET TMU A 901 21 HET TMU B 902 21 HETNAM TMU N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA FORMUL 3 TMU 2(C12 H12 N4 O4 S) FORMUL 5 HOH *373(H2 O) HELIX 1 1 ASN A 95 LEU A 104 1 10 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 ALA A 224 PHE A 229 1 6 HELIX 6 6 SER A 236 GLY A 253 1 18 HELIX 7 7 SER A 261 GLY A 274 1 14 HELIX 8 8 THR A 277 ASN A 285 1 9 HELIX 9 9 PRO A 300 VAL A 304 5 5 HELIX 10 10 PRO A 310 LEU A 321 1 12 HELIX 11 11 THR A 324 ARG A 328 5 5 HELIX 12 12 THR A 330 ALA A 336 1 7 HELIX 13 13 HIS A 337 ASP A 345 5 9 HELIX 14 14 THR A 363 SER A 368 1 6 HELIX 15 15 ASN A 370 PRO A 372 5 3 HELIX 16 16 LEU A 373 ILE A 378 1 6 HELIX 17 17 ASN B 95 ARG B 102 1 8 HELIX 18 18 VAL B 139 ALA B 149 1 11 HELIX 19 19 PRO B 154 PHE B 175 1 22 HELIX 20 20 LYS B 183 GLN B 185 5 3 HELIX 21 21 ALA B 224 PHE B 229 1 6 HELIX 22 22 SER B 236 GLY B 253 1 18 HELIX 23 23 SER B 261 GLY B 274 1 14 HELIX 24 24 THR B 277 ASN B 285 1 9 HELIX 25 25 PRO B 310 LEU B 321 1 12 HELIX 26 26 THR B 324 ARG B 328 5 5 HELIX 27 27 THR B 330 ALA B 336 1 7 HELIX 28 28 HIS B 337 ASP B 345 5 9 HELIX 29 29 THR B 363 SER B 368 1 6 HELIX 30 30 ASN B 370 PRO B 372 5 3 HELIX 31 31 LEU B 373 ILE B 378 1 6 HELIX 32 32 PRO B 379 ILE B 384 5 6 SHEET 1 A 7 THR A 38 PRO A 44 0 SHEET 2 A 7 GLN A 52 GLY A 65 -1 O VAL A 54 N VAL A 40 SHEET 3 A 7 GLY A 68 LEU A 75 -1 O GLN A 72 N LYS A 60 SHEET 4 A 7 LEU A 81 LEU A 88 -1 O LYS A 86 N VAL A 69 SHEET 5 A 7 TYR A 127 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 A 7 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 7 A 7 THR A 38 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 B 3 GLU A 137 THR A 138 0 SHEET 2 B 3 LEU A 187 LEU A 189 -1 O LEU A 189 N GLU A 137 SHEET 3 B 3 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 C 2 ILE A 177 CYS A 178 0 SHEET 2 C 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 D 7 THR B 38 PRO B 44 0 SHEET 2 D 7 GLN B 52 GLY B 63 -1 O VAL B 54 N VAL B 40 SHEET 3 D 7 VAL B 69 LEU B 75 -1 O GLN B 72 N LYS B 60 SHEET 4 D 7 LEU B 81 LEU B 88 -1 O VAL B 82 N ALA B 73 SHEET 5 D 7 TYR B 127 ASP B 133 -1 O LEU B 128 N VAL B 87 SHEET 6 D 7 LEU B 112 SER B 118 -1 N SER B 118 O TYR B 127 SHEET 7 D 7 THR B 38 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 E 3 GLU B 137 THR B 138 0 SHEET 2 E 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 E 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 F 2 ILE B 177 CYS B 178 0 SHEET 2 F 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 SITE 1 AC1 12 ILE A 62 VAL A 70 ALA A 83 LEU A 132 SITE 2 AC1 12 ASP A 133 TYR A 134 VAL A 135 PRO A 136 SITE 3 AC1 12 ARG A 141 LEU A 188 HOH A 626 HOH A 817 SITE 1 AC2 12 ILE B 62 VAL B 70 ALA B 83 LEU B 132 SITE 2 AC2 12 ASP B 133 TYR B 134 VAL B 135 PRO B 136 SITE 3 AC2 12 ARG B 141 LEU B 188 HOH B 749 HOH B 762 CRYST1 82.584 84.913 178.424 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012109 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011777 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005605 0.00000